Tobin Schilke, CFO: Revance Therapeutics RVNC Sell · Filed 23/05/16

Trade details

Type: Insider sale
Amount: $739,404.55
Shares · price: 21,401 sh · $34.55 a share
Held after: 84,029 sh
Stock: Revance Therapeutics RVNC
Person: Tobin SchilkeCFO
Trade date: 23/05/15
Filed: 23/05/16
Days to filing: 1 days

Sold 20.3% of holdings

Share of holding sold: 20.3%

Revance Therapeutics trades, last 26 weeks

What else happened in Revance Therapeutics around then

Filed or reported within 30 days of the trade day · 23/04/15~23/06/14

Tobin Schilke's recent trades

Tobin SchilkeCFO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$266.3K
6,713 sh
$266.3K
Filed 03/04
Traded 03/03
Tobin SchilkeCFO
SellRevance Therapeutics
Sell
Revance Therapeutics
RVNC
$47.2K
9,361 sh
$47.2K
Filed 24/03/19
Traded 24/03/18
Tobin SchilkeCFO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$42.6K
1,701 sh
$42.6K
Filed 23/07/05
Traded 23/07/03
Tobin SchilkeCFO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$82.6K
2,701 sh
$82.6K
Filed 23/06/05
Traded 23/06/01
Tobin SchilkeCFO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$15.5K
500 sh
$15.5K
Filed 23/06/05
Traded 23/06/02